Scientists at the NIH s National Institute of Allergy and Infectious Diseases (NIAID) have come up with a cocktail of VLPs that provides extraordinary coverage against eight flu strains in mice. Ninety-five percent of mice that were subjected to a lethal challenge of these strains survived, while only five percent of the mice that received mock (inactive, control) vaccines lived.
